First EpiSeedLink Consortium Publication in BMC Plant Biology
It’s the first of many more to come!
Fronted image from Freepick
New genomic techniques in the European Union
NGTs in the EU : A Significant Progress, but the Discussion Is Not Over Yet.
✅The legislative proposal on plants obtained through new genomic techniques (NGTs) has progressed, with EU Member States’ deputy ambassadors endorsing the Council's negotiating mandate on March 14.
✅This advancement allows the proposal to enter its final stage, where the Council will engage in trilogue negotiations with the European Parliament to finalize the regulation's text. Once a common version is agreed upon, both institutions will vote separately, and if approved, implementation will take an additional two years.
However, scrutiny and advocacy remain crucial during this phase.
▶️ A key issue in the negotiations is the European Parliament’s demand for a total ban on patenting new NGT-derived plants to prevent monopolies, while the Council supports patenting.
▶️ Additionally, there is a disagreement on labeling and traceability, with the Parliament advocating for mandatory labeling of NGT products, whereas the Council suggests no special labeling is needed for products developed using modern genetic engineering techniques.
✳️ It is vital for policymakers and stakeholders to engage in constructive dialogue to develop a regulatory framework that fosters innovation and supports a sustainable agricultural sector in Europe.
✳️ The need for science-based policies to address climate change is urgent, and farmers require access to tools that enhance productivity and protect biodiversity.
✳️ Continued advocacy for plant breeding innovation is essential, and stakeholders are encouraged to get involved.